eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.33 | $0 | -$2M |
| 2026 Q1 | -0.28 | $0 | -$2M |
| 2025 Q4 | -0.32 | $0 | -$2M |
| 2025 Q3 | -0.27 | $0 | -$2M |
| 2025 Q2 | -0.28 | $0 | -$2M |
| 2025 Q1 | -0.22 | $0 | -$1M |
| 2024 Q4 |
| -0.45 |
| $0 |
| -$6M |
| 2024 Q3 | -0.20 | $0 | -$541,524 |